Clinical Trial

Pre-emptive Endoscopic Vacuum Therapy Reduces the Incidence of Anastomotic Leakage After Colorectal Cancer Surgery

Recruiting
View on ClinicalTrials.gov →
Summary
Evaluate the safety and efficacy of postoperative Pre-emptive EVT (PEVT) in reducing the incidence of anastomotic leaks within 30 days after surgery in patients with colorectal cancer. Compare the differences between the PEVT group and the control group in terms of operation time, length of hospital stay, and total medical costs. Analyze the incidence of other postoperative complications in the two groups, such as wound infection, abdominal abscess, and intestinal obstruction. Assess the impact of PEVT on postoperative recovery indicators, including time to first flatus, time to first defecation, and time to ambulation. Observe the occurrence of PEVT-related adverse events, such as device displacement, bleeding, and infection.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-09-28.
Trial Details
NCT Number NCT07208786
Lead Sponsor Nanchong Central Hospital
Conditions Colorectal Cancer, Colorectal Surgery, Complications, Anastomotic Leakage, Endoscopic Vacuum Therapy
Enrollment 110 participants
Start Date 2025-09-22
Primary Completion 2026-10-10 (estimated)
Study Completion 2026-12-30 (estimated)
Updated on ClinicalTrials.gov 2026-04-02